\documentclass[aspectratio=169]{beamer}
%\documentclass[handout]{beamer}

% language settings
%\usepackage{fontspec, polyglossia}
%\setdefaultlanguage{magyar}

% common packages
\usepackage{amsmath, multimedia, hyperref, color, multirow}
%\usepackage{graphicx}

% TikZ
\usepackage{tikz}
%\usetikzlibrary{arrows.meta, decorations.pathmorphing, decorations.pathreplacing, shapes.geometric,mindmap}
%\usetikzlibrary{shapes.geometric,fadings,bayesnet}

% beamer styles
\mode<presentation>{
\usetheme{Warsaw}
%\usetheme{Antibes}
\usecolortheme{beaver}
%\usecolortheme{seahorse}
%\usefonttheme{structureitalicserif}
\setbeamercovered{transparent}
}
\setbeamertemplate{blocks}[rounded][shadow=true]
\AtBeginSubsection[]{
  \begin{frame}<beamer>{Contents}
    \tableofcontents[currentsection,currentsubsection]
  \end{frame}
}
%\useoutertheme[]{tree}

% title, etc
%\title{Network based drug repurposing for Alzheimer's disease}
%\title{A multi-OMIC network based approach to drug repurposing for Alzheimer's}
\subtitle{A subtitle may be shorter and more technical}
\author{See poster \#97 for more details!}
\date{Attila Jones}

\begin{document}

\newcommand{\mytitle}{\large Drug Repurposing Opportunities for
	Alzheimerâ€™s Disease from Multiomics\\
	\footnotesize{\emph{Attila Jones$^1$, Evan Wu$^2$, Sudhir Varma, Hae Kyung Im$^2$, Madhav Thambisetty$^1$}
\;$1$: LBN, NIA $2$: U.~Chicago}}

\begin{frame}{\mytitle }

\begin{columns}[t]
\begin{column}{0.4\textwidth}
\begin{center}
	Score $>2,000$ drugs approved for non-AD indications
\end{center}

\includegraphics[width=0.9\columnwidth]{../../../figures/by-me/drug-target-disgene-network/drug-target-disgene-network-scores.pdf}
\end{column}

\begin{column}{0.6\textwidth}
\begin{center}
	Three top-scoring drugs acting on AD risk genes
\end{center}

\includegraphics[width=\columnwidth]{../../results/2022-09-26-selected-drugs/knowledge-dtn-anonymized.sif.pdf}
\end{column}
\end{columns}
\end{frame}

\begin{frame}{\mytitle }
	

\begin{columns}[t]
\begin{column}{0.5\textwidth}
\begin{center}
	Experimental validation: neuroprotective function in cell based assays
\end{center}

\includegraphics[width=0.75\columnwidth]{../../../figures/from-others/CTNS-cell-culture-screen.png}
\end{column}

\begin{column}{0.5\textwidth}

\includegraphics[height=0.8\textheight]{../../notebooks/2022-09-21-cell-based-assays/named-figure/cell-based-assays-simplified-anonimized.pdf}
\end{column}
\end{columns}
\end{frame}

\end{document}


\begin{columns}[t]
\begin{column}{0.5\textwidth}

\end{column}

\begin{column}{0.5\textwidth}

\end{column}
\end{columns}
